Cargando…

Anticoagulation Control with Acenocoumarol or Warfarin in Non-Valvular Atrial Fibrillation in Primary Care (Fantas-TIC Study)

Introduction: The use of vitamin K antagonists (VKAs) in non-valvular atrial fibrillation (NVAF) is complicated due to the narrow therapeutic margin they present and their unpredictable dose–response relationship. Most studies are based on warfarin, with the results being extrapolated to acenocoumar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dalmau Llorca, M. Rosa, Aguilar Martín, Carina, Carrasco-Querol, Noèlia, Hernández Rojas, Zojaina, Forcadell Drago, Emma, Rodríguez Cumplido, Dolores, Castro Blanco, Elisabet, Gonçalves, Alessandra Queiroga, Fernández-Sáez, José
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8199061/ https://www.ncbi.nlm.nih.gov/pubmed/34073370 http://dx.doi.org/10.3390/ijerph18115700

Ejemplares similares

Gender and Socioeconomic Inequality in the Prescription of Direct Oral Anticoagulants in Patients with Non-Valvular Atrial Fibrillation in Primary Care in Catalonia (Fantas-TIC Study)
por: Dalmau Llorca, Mª Rosa, et al.
Publicado: (2021)

Oral Anticoagulant Adequacy in Non-Valvular Atrial Fibrillation in Primary Care: A Cross-Sectional Study Using Real-World Data (Fantas-TIC Study)
por: Dalmau Llorca, M. Rosa, et al.
Publicado: (2021)

Cost-effectiveness of direct oral anticoagulants versus vitamin K antagonist in atrial fibrillation: A study protocol using Real-World Data from Catalonia (FantasTIC Study)
por: Hernández Rojas, Zojaina, et al.
Publicado: (2020)

Concordance between the Clinical Diagnosis of Influenza in Primary Care and Epidemiological Surveillance Systems (PREVIGrip Study)
por: Aguilar Martín, Carina, et al.
Publicado: (2022)

A new clinical decision support tool for improving the adequacy of anticoagulant therapy and reducing the incidence of stroke in nonvalvular atrial fibrillation: A randomized clinical trial in primary care
por: Dalmau Llorca, Maria Rosa, et al.
Publicado: (2018)

Early Detection of the Start of the Influenza Epidemic Using Surveillance Systems in Catalonia (PREVIGrip Study)
por: Dalmau Llorca, M. Rosa, et al.
Publicado: (2022)

Ten-Year Follow-Up of Clinical Governance Implementation in Primary Care: Improving Screening, Diagnosis and Control of Cardiovascular Risk Factors
por: Aguilar Martín, Carina, et al.
Publicado: (2019)

Impact of Implementing a Dyslipidemia Management Guideline on Cholesterol Control for Secondary Prevention of Ischemic Heart Disease in Primary Care
por: Forcadell Drago, Emma, et al.
Publicado: (2020)

Comparison of Anticoagulation Quality between Acenocoumarol and Warfarin in Patients with Mechanical Prosthetic Heart Valves: Insights from the Nationwide PLECTRUM Study
por: Menichelli, Danilo, et al.
Publicado: (2021)

Acenocoumarol’s pharmacokinetic: linear or not?
por: Kumar, Parveen, et al.
Publicado: (2019)

Improving learning by playing with an app: The FantaTraining (® )experience with anesthesia trainees.
por: Gibiino, Giovanni, et al.
Publicado: (2022)

Spontaneous spinal epidural hematoma in a patient on acenocoumarol for valvular atrial fibrillation: A rare case report
por: El-azrak, Mohammed, et al.
Publicado: (2021)

Cost-effectiveness Analysis of Rivaroxaban versus Acenocoumarol in the Prevention of Stroke in Patients with Non-valvular Atrial Fibrillation in Spain
por: Rubio-Terrés, Carlos, et al.
Publicado: (2016)

Effectiveness, cost-utility, and benefits of a multicomponent therapy to improve the quality of life of patients with fibromyalgia in primary care: A mixed methods study protocol
por: Caballol Angelats, Rosa, et al.
Publicado: (2019)

Diferencias entre MDRD-4 y CG en la prevalencia de la insuficiencia renal y sus variables asociadas en pacientes diabéticos tipo 2
por: Dalmau Llorca, Maria Rosa, et al.
Publicado: (2016)

Acenocoumarol: Lack of efficacy: case report
Publicado: (2022)

Toxidermie médicamenteuse secondaire à l'acénocoumarol
por: Khammassi, Naziha, et al.
Publicado: (2015)

Fatigue in patients with chronic obstructive pulmonary disease: protocol of the Dutch multicentre, longitudinal, observational FAntasTIGUE study
por: Goërtz, Yvonne M J, et al.
Publicado: (2018)

Changing trends in the use of novel oral anticoagulants and warfarin for treating non-valvular atrial fibrillation
por: Birkinshaw, Alexander, et al.
Publicado: (2020)

Effectiveness and health benefits of a nutritional, chronobiological and physical exercise primary care intervention in fibromyalgia and chronic fatigue syndrome: SYNCHRONIZE + mixed-methods study protocol
por: Carrasco-Querol, Noèlia, et al.
Publicado: (2023)

Acenocoumarol, an Anticoagulant Drug, Prevents Melanogenesis in B16F10 Melanoma Cells
por: Han, Hyunju, et al.
Publicado: (2023)

Novel Associations of VKORC1 Variants with Higher Acenocoumarol Requirements
por: Anton, Ana Isabel, et al.
Publicado: (2013)

Protective Effect of Pretreatment with Acenocoumarol in Cerulein-Induced Acute Pancreatitis
por: Warzecha, Zygmunt, et al.
Publicado: (2016)

Unusual localization of bleeding under acenocoumarol: Spinal subdural hematoma
por: Aissa, Ismail, et al.
Publicado: (2019)

Acenocoumarol-Induced Diffuse Alveolar Hemorrhage: A Case Report
por: Pawar, Twinkle, et al.
Publicado: (2023)

Native valve disease in patients with non-valvular atrial fibrillation on warfarin or rivaroxaban
por: Breithardt, Günter, et al.
Publicado: (2016)

Safety and Efficacy of Novel Oral Anticoagulants Versus Warfarin in Medicare Beneficiaries With Atrial Fibrillation and Valvular Heart Disease
por: Briasoulis, Alexandros, et al.
Publicado: (2018)

Comparison of Direct Oral Anticoagulants and Warfarin in the Prevention of Stroke in Patients With Valvular Heart Disease: A Meta-Analysis
por: Batool, Saima, et al.
Publicado: (2022)

Direct Acting Oral Anticoagulant vs. Warfarin in the Prevention of Thromboembolism in Patients With Non-valvular Atrial Fibrillation With Valvular Heart Disease—A Systematic Review and Meta-Analysis
por: Martha, Januar Wibawa, et al.
Publicado: (2021)

The Association Between Long-Term Acenocoumarol Treatment and Vitamin D Deficiency
por: Sawicka-Powierza, Jolanta, et al.
Publicado: (2018)

Unintentional ingestion of a high dose of acenocoumarol in a young child
por: Brands, Martijn R, et al.
Publicado: (2021)

Comparison of the New Oral Anticoagulants and Warfarin in Patients with Atrial Fibrillation and Valvular Heart Disease: Systematic Review and Meta-Analysis
por: de Souza Lima Bitar, Yasmin, et al.
Publicado: (2019)

Association between direct-acting oral anticoagulants vs. warfarin with the risk of osteoporosis in patients with non-valvular atrial fibrillation
por: Akhtar, Tauseef, et al.
Publicado: (2020)

Is Lighter Intensity of Warfarin Therapy Enough for Korean Patients with Non-Valvular Atrial Fibrillation?
por: Lee, So-Ryoung
Publicado: (2019)

Economic and Clinical Impact of Stroke and Warfarin Use for Patients with Non-valvular Atrial Fibrillation
por: Wang, Li, et al.
Publicado: (2013)

Acute Kidney Injury in Patients with Non-Valvular Atrial Fibrillation Treated with Rivaroxaban or Warfarin: A Population-Based Study from the United Kingdom
por: González-Pérez, Antonio, et al.
Publicado: (2022)

Effectiveness and safety of dabigatran versus acenocoumarol in ‘real-world’ patients with atrial fibrillation
por: Korenstra, Jennie, et al.
Publicado: (2016)

Spontaneous Iliopsoas Hematoma in a Patient on Acenocoumarol: Report of a Rare Case
por: El Boté, Hicham, et al.
Publicado: (2023)

Aprendizaje, competencias y TIC /
por: López Carrasco, Miguel Ángel
Publicado: (2017)

Comparison of health-related quality of life among patients using novel oral anticoagulants or warfarin for non-valvular atrial fibrillation
por: Balcı, Kevser Gülcihan, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_lhthroql6tvl9969ie7qc7jhi3